JS

Jozef Stojka

Active Director Director DIN 08472060
DIN 08472060 First appointment Jun 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Jozef Stojka

Data last updated:

Jozef Stojka is a Director at Arenis Medico Private Limited (since 2019). The company operates in Chemicals.

DIN 08472060
Primary Designation Director
Industry Chemicals
First Appointment 04 Jun 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arenis Medico Private Limited U24296MH2019PTC326305
Director04 Jun 20192019Active

Board colleagues of Jozef Stojka

NameDINCompanyDesignation
Lukas Dovjak08472061Arenis Medico Private LimitedAdditional Director
Mohammad Sadik Shafiqur Rehaman Ansari09014975Arenis Medico Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Arenis Medico Private Limited
Premium access

Shareholding and investment profile for Jozef Stojka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jozef Stojka

Jozef Stojka currently holds 1 directorship: Arenis Medico Private Limited (Director, since 04 Jun 2019).

Jozef Stojka was first appointed on 04 Jun 2019 as Director at Arenis Medico Private Limited.

The current boards of Jozef Stojka's companies include Lukas Dovjak (Arenis Medico Private Limited), Mohammad Sadik Shafiqur Rehaman Ansari (Arenis Medico Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available